Haedicke, Katja
Agemy, Lilach
Omar, Murad http://orcid.org/0000-0001-9052-0269
Berezhnoi, Andrei
Roberts, Sheryl http://orcid.org/0000-0002-2326-9120
Longo-Machado, Camila
Skubal, Magdalena
Nagar, Karan
Hsu, Hsiao-Ting
Kim, Kwanghee http://orcid.org/0000-0003-0544-6792
Reiner, Thomas http://orcid.org/0000-0002-7819-5480
Coleman, Jonathan http://orcid.org/0000-0002-6428-7835
Ntziachristos, Vasilis http://orcid.org/0000-0002-9988-0233
Scherz, Avigdor
Grimm, Jan http://orcid.org/0000-0002-5282-9385
Article History
Received: 10 December 2018
Accepted: 6 February 2020
First Online: 12 March 2020
Competing interests
: V.N. is a shareholder in iThera Medical GmbH in Munich, Germany, which produces a commercial version of the monospectral RSOM (not used in this study). A.S. is an inventor of padeliporfin and has a financial interest from licensing fees.